Page last updated: 2024-08-18

pyrroles and Morbid Obesity

pyrroles has been researched along with Morbid Obesity in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asberg, A; Christensen, H; Hjelmesaeth, J; Jakobsen, GS; Jenssen, T; Reubsaet, JL; Sandbu, R; Skottheim, IB; Stormark, K	1
Asberg, A; Christensen, H; Hjelmesaeth, J; Jakobsen, GS; Jenssen, T; Sandbu, R; Skottheim, IB; Stormark, K	1
Asberg, A; Christensen, H; Hjelmesæth, J; Jakobsen, GS; Røislien, J; Sandbu, R; Skottheim, IB	1
Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F	1

Trials

3 trial(s) available for pyrroles and Morbid Obesity

Article	Year
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. Clinical pharmacology and therapeutics, 2009, Volume: 86, Issue:3 Topics: Acids; Adult; Area Under Curve; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; DNA; Female; Gastric Bypass; Genotype; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction	2009
Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch. Clinical pharmacology and therapeutics, 2010, Volume: 87, Issue:6 Topics: Adult; Aged; Area Under Curve; Atorvastatin; Biliopancreatic Diversion; Biological Availability; Dose-Response Relationship, Drug; Duodenum; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestine, Small; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Pyrroles	2010
Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin. Surgical endoscopy, 2013, Volume: 27, Issue:6 Topics: Adult; Atorvastatin; Biliopancreatic Diversion; Biological Availability; Female; Gastric Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Obesity, Morbid; Prospective Studies; Pyrroles	2013

Other Studies

1 other study(ies) available for pyrroles and Morbid Obesity

Article	Year
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reproductive toxicology (Elmsford, N.Y.), 2004, Volume: 18, Issue:4 Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones	2004

Article

Year

Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.

Reproductive toxicology (Elmsford, N.Y.), 2004, Volume: 18, Issue:4

Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones

2004